IAF BioChem
Executive Summary
Invests $ 40 mil. (Canadian) to construct vaccine production laboratory and an R&D center in Laval, Quebec, Canada. Expansion, slated for completion in two to three years, will increase the staff by 300 employees, the company predicts. IAF BioChem and its subsidiary IAF BioVac currently employ about 150 people.